Repair Biotechnologies
PrivateLast Round
Seed
Nov 25, 2025
Est. Valuation
$74.42M
Total Funding Raised
$36.18M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Repair Biotechnologies is a biotechnology company developing therapies that target and reduce cholesterol levels using a proprietary Cholesterol Degrading Platform (CDP) to address medical conditions caused by excess cholesterol accumulation, such as atherosclerosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Repair Biotechnologies Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Repair Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 25, 2025 | ||||
| Series A Extension | Mar 26, 2024 | ||||
| Series A | Jun 16, 2023 | ||||
| SAFE | May 27, 2022 | ||||
| Pre Seed | Feb 23, 2021 | ||||
Seed | Sep 1, 2020 |
Repair Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Grapeseed | SAFE |
| Bioverge | SAFE, Series A, Seed |
| Longevitytech.fund | SAFE, Series A |
| VitaDAO | SAFE |
| Thynk Capital | SAFE, Series A, Seed |
| Healthspan Capital | SAFE, Seed, Series A |
| SENS Research Foundation | SAFE, Pre Seed, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 25, 2025
Raised $11.4M from 100 Plus Capital, Bioverge, and Healthspan Capital.
- Nov 19, 2025
Developing novel mRNA therapy to stabilize atherosclerotic plaques.
Repair Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Repair Biotechnologies's valuation, stock price, and market status.